E3 PreliminaryPreliminaryPEM unclearCase-ControlPeer-reviewedMachine draft
[The "anti-Ki" syndrome: major clinical features].
Matsunaga, K · Rinsho byori. The Japanese journal of clinical pathology · 1993
Quick Summary
Researchers found that four patients with autoimmune diseases had high levels of anti-Ki antibodies, a type of immune marker. These patients shared several symptoms including hair loss, severe fatigue, muscle weakness, joint inflammation, dry mouth, and blood sugar problems. The study suggests that this antibody pattern may be related to conditions like chronic fatigue syndrome and fibromyalgia.
Why It Matters
This study identifies a potential autoimmune mechanism (anti-Ki antibodies) that bridges lupus, sicca syndrome, and ME/CFS-like fatigue states. Understanding antibody-mediated pathways in ME/CFS could lead to targeted diagnostic tests and treatment strategies for severely fatigued patients.
Observed Findings
- Four of 172 connective tissue disease patients had high-titer anti-Ki antibodies (>1/256)
- Common features in anti-Ki positive patients: alopecia, disabling chronic fatigue, muscle weakness, tenosynovitis, dry mouth, and abnormal glucose tolerance
- Anti-Ki antibodies were found in both sicca and nonsicca lupus presentations
- One patient demonstrated concurrent anti-insulin receptor antibody positivity and pituitary dysfunction
Inferred Conclusions
- Anti-Ki antibody syndrome may represent a distinct subset of sicca lupus with specific clinical features
- Anti-Ki antibody syndrome shares clinical and laboratory overlap with chronic fatigue syndrome and fibromyalgia, suggesting shared etiologic or pathogenetic mechanisms
- Autoimmune mechanisms involving multiple antibody types and endocrine dysfunction may contribute to severe fatigue states
Remaining Questions
- What is the prevalence of anti-Ki antibodies in primary ME/CFS populations versus connective tissue disease patients?
- Do anti-Ki antibody levels correlate with fatigue severity, and do they change with disease progression or treatment?
- What is the mechanistic relationship between anti-Ki antibodies, insulin receptor antibodies, and pituitary insufficiency in driving fatigue?
What This Study Does Not Prove
This small case series does not establish that anti-Ki antibodies directly cause ME/CFS or prove a causal relationship between antibodies and fatigue. The study cannot confirm whether anti-Ki syndrome is a distinct disease entity or merely overlap between known autoimmune conditions. No longitudinal follow-up or untreated control comparisons are provided.
Tags
Symptom:PainFatigue
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:No ControlsSmall SampleExploratory Only
Metadata
- PMID
- 8371504
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →